SIBO Testing Problems: Why Current Gut Bacteria Tests Often Fail
- Authors
- Ayesha Shah, Gerald Holtmann, Peter R Gibson
- Journal
- JGH Open
- Year
- 2026
- DOI
- 10.1002/jgh3.70419
- Study Type
- clinical
- Peer Reviewed
- Yes
- Country
- Australia
- Health Condition
- Small Intestinal Bacterial Overgrowth (SIBO)
- Body System
- Digestive
TL;DR
Right now, doctors have a hard time figuring out if someone actually has SIBO (too many bacteria in the small intestine) because the tests they use give wrong answers a lot of the time. Scientists think we need better ways to test for it so doctors can actually help patients instead of guessing.
Key Finding
Current diagnostic tests for SIBO, particularly breath-hydrogen testing, frequently produce false positive and negative results, and the gold standard bacterial culture method is impractical for clinical use, creating significant uncertainty in diagnosis and treatment decisions.
Summary
This article reviews the history and current understanding of SIBO (small intestinal bacterial overgrowth), a condition where abnormal bacteria populations in the small intestine may contribute to digestive symptoms and other health problems. The authors highlight major problems with how SIBO is currently diagnosed—existing tests produce unreliable results and can give false positives or false negatives—and propose that better diagnostic methods using molecular analysis of bacteria in intestinal tissue samples would help clarify SIBO's actual role in disease.
Practical Takeaway
This is a review article that critiques existing SIBO diagnostics rather than testing hydrogen water or any treatment. It does not provide evidence about hydrogen water's effects on SIBO or related conditions. Anyone considering SIBO testing or treatment should be aware that current diagnostic methods have substantial limitations, as this review documents.
Abstract
Small intestinal bacterial overgrowth (SIBO) has evolved from a severe debilitating illness to a clinical spectrum associated with abnormalities of microbial populations in the small intestine. It is best described as a pathophysiological state that may contribute to symptoms or other pathology in a wide range of gastrointestinal conditions that include disorders of gut-brain interaction, inflammatory bowel disease, and chronic liver disease. The controversy surrounding SIBO largely rests on diagnostic limitations of currently widely used diagnostic tests. The gold standard test of bacterial culture of proximal small intestinal fluid will miss the majority of bacteria, has severe methodological limitations, and is clinically uncommonly used. Breath-hydrogen testing after oral glucose or lactulose ingestion is associated with falsely positive and negative results, due largely to the inability to accurately define where in the gastrointestinal tract the hydrogen is being generated. Such performance characteristics raise concerns regarding its application to clinical decision-making in the individual patient. Therapies such as antibiotics can normalize breath test findings and ameliorate symptoms, but whether this is due to an action on the small intestinal microbiota is uncertain. It is proposed that conceptual modifications that include the assessment of the mucosa-associated microbiota in biopsies obtained with minimal contamination, molecular and functional characterization of the microbiota, rather than purely culture-based density of bacteria, and expansion of the definition of SIBO to small intestinal dysbiosis will facilitate more precision and resolve the controversial place of SIBO in clinical practice.